RXST Q4 2023 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$29M+77.6% YoY

Gross Profit

$18M61.8% margin

Operating Income

-$11M-38.0% margin

Net Income

-$9M-32.1% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

-6.8%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$183M

Total Liabilities

$22M

Stockholders' Equity

$160M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$16M	+77.6%
Gross Profit	$18M	$7M	+137.9%
Operating Income	-$11M	-$15M	+27.6%
Net Income	-$9M	-$16M	+41.2%